Rate My Professor Andrew Amis

Professor Andrew Amis, FREng, DSc(Eng), PhD, is Professor of Orthopaedic Biomechanics in the Department of Mechanical Engineering, Faculty of Engineering, at Imperial College London, with a joint appointment in the Department of Surgery and Cancer. He joined the Biomechanics Group at Imperial College London in 1979 as a junior lecturer following a short period as a designer at Rolls-Royce. Amis advanced to lead the Biomechanics Group, which holds an international reputation for research on the biomechanics of human joints, tendons, and ligaments. He served as Director of Research for the Department of Mechanical Engineering. His career has focused on advancing orthopaedic biomechanics through rigorous mechanical analyses and collaborations with surgeons.

Amis's research specializations encompass the design of artificial human joints, soft tissue mechanics, and the stability and kinematics of total and partial knee prostheses, examining how implant designs and surgical variables affect joint function to improve treatments for arthritis and sports injuries. He has produced numerous publications in refereed journals, including highly influential works such as "Anatomy and biomechanics of the medial patellofemoral ligament" (The Knee, 2003), "Functional anatomy of the medial patellofemoral ligament and posteromedial capsule of the knee" (Journal of Bone and Joint Surgery, 2004), and "Anterolateral knee biomechanics" (Knee Surgery, Sports Traumatology, Arthroscopy, 2017). Major honors include election as a Fellow of the Royal Academy of Engineering in 2014 and, in 2017, becoming the first engineer to receive an Honorary Fellowship from the British Orthopaedic Association for outstanding contributions to Trauma and Orthopaedics. Amis influences the field through joint publications with surgeons, supervision in his laboratory, presentations at surgical conferences, planning of orthopaedic events, and more than twenty patents for orthopaedic devices, translating biomechanical research into enhanced clinical practices worldwide.